| WKN: | 923818 |
| ISIN: | US91307C1027 |
| Land: | USA |
| Branche: | Chemie, Pharma, Bio- & Medizintechnik |
| Sektor: | Pharma |
Weshalb die United Therapeutics-Aktie
ein A-Rating hat,
erfahren Sie im Performance-Check
vom 13. April 2026 Info.
| Rang | Datum | Vorjahr | Schluss | Performance |
|---|---|---|---|---|
| 1 | 2013 | 39,65 | 82,65 | 108,45% |
| 2 | 2004 | 9,40 | 17,03 | 81,17% |
| 3 | 2024 | 197,20 | 341,80 | 73,33% |
| 4 | 2005 | 17,03 | 29,29 | 71,99% |
| 5 | 2007 | 20,25 | 34,00 | 67,90% |
| 6 | 2009 | 22,50 | 36,55 | 62,44% |
| 7 | 2021 | 122,00 | 191,00 | 56,56% |
| 8 | 2020 | 79,00 | 122,00 | 54,43% |
| 9 | 2002 | 5,50 | 8,00 | 45,45% |
| 10 | 2022 | 191,00 | 256,60 | 34,35% |
| 11 | 2015 | 108,53 | 145,23 | 33,82% |
| 12 | 2014 | 82,65 | 108,53 | 31,31% |
| 13 | 2010 | 36,55 | 47,64 | 30,34% |
| 14 | 2025 | 341,80 | 427,10 | 24,96% |
| 15 | 2003 | 8,00 | 9,40 | 17,50% |
| 16 | 2026 | 427,10 | 487,00 | 14,02% |
| 17 | 2012 | 36,72 | 39,65 | 7,98% |
| 18 | 2016 | 145,23 | 137,28 | -5,47% |
| 19 | 2017 | 137,28 | 124,48 | -9,32% |
| 20 | 2019 | 91,26 | 79,00 | -13,43% |
| Rang | Datum | Vorjahr | Schluss | Performance |
|---|---|---|---|---|
| 1 | 2000 | 19,00 | 7,17 | -62,26% |
| 2 | 2008 | 34,00 | 22,50 | -33,82% |
| 3 | 2006 | 29,29 | 20,25 | -30,86% |
| 4 | 2018 | 124,48 | 91,26 | -26,69% |
| 5 | 2001 | 7,17 | 5,50 | -23,29% |
| 6 | 2023 | 256,60 | 197,20 | -23,15% |
| 7 | 2011 | 47,64 | 36,72 | -22,92% |
| 8 | 2019 | 91,26 | 79,00 | -13,43% |
| 9 | 2017 | 137,28 | 124,48 | -9,32% |
| 10 | 2016 | 145,23 | 137,28 | -5,47% |
| 11 | 2012 | 36,72 | 39,65 | 7,98% |
| 12 | 2026 | 427,10 | 487,00 | 14,02% |
| 13 | 2003 | 8,00 | 9,40 | 17,50% |
| 14 | 2025 | 341,80 | 427,10 | 24,96% |
| 15 | 2010 | 36,55 | 47,64 | 30,34% |
| 16 | 2014 | 82,65 | 108,53 | 31,31% |
| 17 | 2015 | 108,53 | 145,23 | 33,82% |
| 18 | 2022 | 191,00 | 256,60 | 34,35% |
| 19 | 2002 | 5,50 | 8,00 | 45,45% |
| 20 | 2020 | 79,00 | 122,00 | 54,43% |